Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
We know stopping these drugs altogether results in rebound weight gain
The staff at BodEvolve Bariatrics provides all types of weight-loss solutions, ranging from medical weight management options to the life-altering bariatric surgery procedures that many Dallas-Fort Worth area individuals choose
Effective January 1, 2026, Medi-Cal Rx is excluding coverage for GLP-1 medications prescribed for weight loss: [12] Wegovy, Zepbound, Saxenda: Completely removed from the Contract Drugs List for weight loss Ozempic, Mounjaro, Rybelsus: Restricted to Type 2 diabetes onlyweight loss claims will auto-deny Existing prior authorizations end December 31, 2025 Exceptions: Members under age 21 may still qualify via EPSDT Non-weight-loss indications (Zepbound for OSA, Wegovy for cardiovascular) may still get PA approval This does NOT affect Kaiser commercial or employer-sponsored plansonly Medi-Cal members
Indications for Semaglutide While semaglutide was initially developed to treat type 2 diabetes (marketed as Ozempic), it has been shown to be effective for weight management in individuals without diabetes as well
From consultation to completion, the installation process is handled with structured oversight
US$ 28.88
US$ 20.42
US$ 22.09
US$ 23.44
US$ 29.62
US$ 23.90
US$ 23.46
US$ 27.64
US$ 21.93
US$ 22.61
